Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gately, US

Charles A. Gately, Arlington, VA US

Patent application numberDescriptionPublished
20120095796SYSTEM AND METHOD FOR MOBILE SURVEY MANAGEMENT - A method for mobile survey management includes creating a survey database for storing surveyee information, survey question information, survey results information, the surveyee information including a list of a plurality of surveyees to be visited by a plurality of surveyors, and the survey question information including a survey question to ask to the plurality of surveyees, assigning one or more surveyors to one or more surveyees, transmitting the surveyee information including the list of one or more surveyees assigned to each surveyor to each surveyor's mobile survey device along with the survey question information, displaying the list of the one or more surveyees assigned to each surveyor on each surveyor's mobile survey device, displaying the survey question on the display of each surveyor's mobile survey device, entering an answer by each surveyee to the survey question to the mobile survey device, transmitting the survey result from each mobile survey device to the database, the survey result comprising the answer by each surveyee to the survey question, and updating the survey results information in the survey database based on the survey results transmitted from the plurality of mobile survey devices in a real-time basis.04-19-2012

Daniel A. Gately, Duluth, GA US

Patent application numberDescriptionPublished
20100170182FIBERGLASS SIDING - A fiberglass siding piece may be formed. The fiberglass siding piece includes an upper seating portion of the fiberglass siding piece. The upper seating portion includes an angled siding seat. The fiberglass siding piece further includes a main portion of the fiberglass siding piece, and a lower seating portion of the fiberglass siding piece. The lower seating portion includes an angled siding seat. The angled siding seat of the upper seating portion is configured to receive the angled siding seat of the lower seating portion of an adjacent fiberglass siding piece. The upper seating portion may include slots configured to accept fasteners to fasten the fiberglass siding piece to a building.07-08-2010

Dennis Gately, San Diego, CA US

Patent application numberDescriptionPublished
20090053227Prostate Specific Genes and The Use Thereof in Design of Therapeutics - Genes that are upregulated in human prostate tumor tissues and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of prostate cancer. A preferred target gene is Kv3.2.02-26-2009

Dennis P. Gately, San Diego, CA US

Patent application numberDescriptionPublished
20080213166Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas - Isolated nucleic acids and proteins that are overexpressed in human cancers, and antibodies that specifically bind the proteins, which are useful diagnostic and therapeutic targets.09-04-2008

Dennis Patrick Gately, San Diego, CA US

Patent application numberDescriptionPublished
20090136495ANTI-HEPCIDIN ANTIBODIES AND USES THEREOF - Monoclonal antibodies are provided that selectively bind human hepcidin-25 and are characterized as having high affinity for human hepcidin-25 and strong human mature hepcidin neutralizing properties. The antibodies of the invention are useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human and for the treatment and diagnosis of mature hepcidin-promoted disorders such as anemia, in a human subject.05-28-2009

Dermot Gately, San Bruno, CA US

Patent application numberDescriptionPublished
20080270294Method and Apparatus for a Verifiable On Line Rejection of an Applicant for Credit - A system and method are disclosed for presenting a reason for the rejection of 10-30-2008
20100262535METHOD AND APPARATUS FOR A VERIFIABLE ON LINE REJECTION OF AN APPLICATION FOR CREDIT - A system and method are disclosed for presenting a reason for the rejection of 5 a credit application from an applicant is disclosed. The method includes obtaining a factor from a credit bureau identified as a factor that influences the FICO score assigned to the application by the credit bureau. The factor identified by the credit bureau is mapped to an internal rejection code. A rejection reason is provided that corresponds to the internal rejection code to the applicant.10-14-2010

Maurice Kent Gately, Morris Plains, NJ US

Patent application numberDescriptionPublished
20080214505Risedronate compositions and their methods of use - A method comprising orally administering to a human or other mammal a pharmaceutical composition comprising from about 65% to about 110% of the cumulative effective dose of risedronate or a pharmaceutically acceptable acid, salt, ester, solvate, or polymorph thereof according to a continuous dosing schedule of one, two, or three consecutive days per month is useful for treating or preventing osteoporosis and other bone metabolic disorders.09-04-2008
20080260827RISEDRONATE COMPOSITIONS AND THEIR METHODS OF USE - A method comprising orally administering to a human or other mammal a pharmaceutical composition comprising from about 65% to about 110% of the cumulative effective dose of risedronate or a pharmaceutically acceptable acid, salt, ester, solvate, or polymorph thereof according to a continuous dosing schedule of one, two, or three consecutive days per month is useful for treating or preventing osteoporosis and other bone metabolic disorders.10-23-2008

Nicholas Gately, Lambertville, NJ US

Patent application numberDescriptionPublished
20090036817IMPLANTABLE FLOW CONNECTOR - An implantable flow connector for fluidically coupling a source tissue-enclosed body space with a destination element, comprising: a conduit having a lumen terminating at an orifice at a first end of the conduit implantable in the source body space through an opening formed in a tissue wall of the source body space, and a second end of the conduit implantable in the destination element through an opening in a surface of the destination element; and a circumferential flange, radially extending from the conduit proximate the conduit first end, configured to be implanted in the source body space adjacent an opening in the tissue wall of the source body space such that the conduit extends through the opening, the flange comprising one or more circumferentially adjacent sections at least one of which has a rigidity that decreases in a radially-increasing direction.02-05-2009
20090036820IMPLANTABLE FLOW CONNECTOR - An implantable flow connector for fluidically coupling a source tissue-enclosed body space with a destination element, comprising: a conduit having a lumen terminating at an orifice at a first end of the conduit implantable in the source body space through an opening formed in a tissue wall of the source body space, and a second end of the conduit implantable in the destination element through an opening in a surface of the destination element; and a circumferential flange, radially extending from the conduit proximate the conduit first end, configured to be implanted in the source body space adjacent an opening in the tissue wall of the source body space such that the conduit extends through the opening, the flange comprising one or more circumferentially adjacent sections at least one of which has a rigidity that decreases in a radially-increasing direction.02-05-2009
20110166654SPINE IMPLANT INSERTION DEVICE AND METHOD - A spinal implant include a top, wherein at least a portion of the top is configured to contact a first vertebra, a bottom, wherein at least a portion of the bottom is configured to contact a second vertebra, a side having a releasable attachment to receive an insertion device and a cam surface to engage a cam on the insertion device07-07-2011
20120041484MEDICAL DEVICE AND PROCEDURE FOR ATTACHING TISSUE TO BONE - The invention pertains to a method and apparatus for attaching tissue to bone. Particularly, the invention relates to bone anchors for receiving (or being pre-loaded with) sutures for connecting to soft tissue that is to be attached to bone, including tools for implanting the bone anchors and facilitating the attachment of soft tissue to bone via the bone anchors and procedures for using the same.02-16-2012

Patent applications by Nicholas Gately, Lambertville, NJ US

Nicholas V. Gately, Lambertville, NJ US

Patent application numberDescriptionPublished
20100228230Shielded Tip Catheter - A multilumen catheter assembly including an elongated body having a proximal end and a distal end and a first lumen having a sidewall extending between the proximal end and the distal end, a first distal opening disposed at the distal end, and a first guide wire opening disposed proximally of the distal end and co-planar with the sidewall. The assembly also includes a second lumen connected to the sidewall and extending from the proximal end toward the distal end, proximally of the distal end. The second lumen includes a second opening extending obliquely away from the sidewall distally toward the first distal opening and a second guide wire opening disposed proximally of the second opening and in a plane generally parallel to the sidewall. A method of inserting the catheter into a vessel is also disclosed.09-09-2010

Patent applications by Nicholas V. Gately, Lambertville, NJ US

Nick Gately, Lambertville, NJ US

Peter Gately, Santa Barbara, CA US

Patent application numberDescriptionPublished
20100007665Do-It-Yourself Photo Realistic Talking Head Creation System and Method - A do-it-yourself photo realistic talking head creation system comprising: a template; handheld device comprising display and video camera having an image output signal of a subject; a computer having a mixer program for mixing the template and image output signal of the subject into a composite image, and an output signal representational of the composite image; a computer adapted to communicate the composite image signal to the display for display to the subject as a composite image; the display and the video camera adapted to allow the video camera to collect the image of the subject, the subject to view the composite image, and the subject to align the image of the subject with the template; storage means having an input for receiving the output signal of the video camera representational of the collected image of the subject and storing the image of the subject substantially aligned with the template.01-14-2010
20100085363Photo Realistic Talking Head Creation, Content Creation, and Distribution System and Method - A system and method for creating, distributing, and viewing photo-realistic talking head based multimedia content over a network, comprising a server and a variety of communication devices, including cell phones and other portable wireless devices, and a software suite, that enables users to communicate with each other through creation, use, and sharing of multimedia content, including photo-realistic talking head animations combined with text, audio, photo, and video content. Content is uploaded to at least one remote server, and accessed via a broad range of devices, such as cell phones, desktop computers, laptop computers, personal digital assistants, and cellular smartphones. Shows comprising the content may be viewed with a media player in various environments, such as internet social networking sites and chat rooms via a web browser application, or applications integrated into the operating systems of the digital devices, and distributed via the internet, cellular wireless networks, and other suitable networks.04-08-2010

Stephen Gately, Scottsdale, AZ US

Patent application numberDescriptionPublished
20090054369PHARMACEUTICAL COMPOSITIONS OF SILICON-CONTAINING SUBSTITUTED ADENOSINE NUCLEOSIDE AMIDE ANALOGS - Novel compositions of silicon-containing anti-metabolite compounds, their preparation and use in methods for treating cancer are described. The silyl group confers lipophilicity that can enhance the penetration of the compounds across the gut wall, cell membranes and blood brain barrier, thus improving therapeutic properties including bioavailability, metabolism, and/or pharmacokinetics. The triorganosilyl group provides compounds having improved pharmacokinetics and anti-tumor activity. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for treatment of diseases and other maladies or conditions involving cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.02-26-2009
20090306015PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS - Novel compositions of silicon-containing sulfhydryl compounds, their preparation and use in methods for treating disease are described. Silicon confers lipophilicity that can enhance the penetration of the silicon derivative sulfhydryl compounds across the gut wall, cell membranes and blood brain barrier, thus improving therapeutic properties including bioavailability, metabolism, and/or pharmacokinetics. The organosilyl group provides compounds having improved pharmacokinetics. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for treatment of diseases and other maladies or conditions and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.12-10-2009
20100069330Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation Inhibitors - Novel compositions of lipophilic organosulfur compounds, their preparation and use in methods for treating disease are described. Silicon confers lipophilicity that can enhance the penetration of the silicon derivative compounds across the gut wall, cell membranes and blood brain barrier, thus improving therapeutic properties including bioavailability, metabolism, and/or pharmacokinetics. The organosilyl group provides compounds having improved pharmacokinetics. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, polymorphic forms, crystalline forms or an amorphous form, pharmaceutical compositions and methods for treatment of diseases, maladies or conditions. Also disclosed are processes for making such compounds as well as intermediates useful in such processes.03-18-2010
20100216130SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS - Methods for determining the genetic predisposition of a human subject to developing ALS are provided herein. These methods include methods for determining the genetic predisposition to any form of ALS, as well as specific methods for determining the genetic predisposition to early onset, late onset, bulbar onset and limb onset ALS. The method can detect amyotrophic lateral sclerosis in a human subject or a specific form of ALS in the subject (early onset, late onset, bulbar onset or limb onset). The method can also detect the risk of developing amyotrophic lateral sclerosis (ALS) in a human subject. The methods utilize the detection of one or more haplotype bocks comprising tag single nucleotide polymorphisms (SNPs). In several embodiments, the methods including detecting the presence of one or more tag SNPs.08-26-2010

Patent applications by Stephen Gately, Scottsdale, AZ US

Stephen F. Gately, Atlanta, GA US

Patent application numberDescriptionPublished
20090092704Granular feed supplement - A ruminant feed composition, having a granulated core having at least one active substance and at least one layer of a coating material surrounding the core.04-09-2009

Timothy Gately, San Francisco, CA US

Patent application numberDescriptionPublished
20110144064Inhibitors of Kynurenine Aminotransferase and Uses Therefor - Provided herein are methods of decreasing a level of kynurenic acid in a cell and of treating a pathophysiological condition in a subject associated with an increase in kynurenic acid in a subject. In these methods the inhibitory action of dicarboxylic acids or derivatives or analogs thereof are effective to inhibit activity of kynurenine aminotransferase II. Also provided is a method of screening for potential inhibitory compounds for kynurenine aminotransferase II. The dicarboxylic acids or derivatives or analogs thereof may have the structural formula, where R06-16-2011